Showing results (331-340 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|May 19, 2017
HIV and the criminalisation of drug use among people who inject drugs: a systematic reviewKora DeBeck, Tessa Cheng, Julio S Montaner, et al.
The Lancet. HIV|July 21, 2018
Palliative care as an essential component of the HIV care continuumRichard Harding
The Lancet. HIV|July 22, 2018
Targeted combination prevention to support female sex workers in Zimbabwe accessing and adhering to antiretrovirals for treatment and prevention of HIV (SAPPH-IRe): a cluster-randomised trialFrances M Cowan, Calum Davey, Elizabeth Fearon, et al.
The Lancet. HIV|June 5, 2018
The finding of casual sex partners on the internet, methamphetamine use for sexual pleasure, and incidence of HIV infection among men who have sex with men in Bangkok, Thailand: an observational cohort studyPhunlerd Piyaraj, Frits van Griensven, Timothy H Holtz, et al.
The Lancet. HIV|September 24, 2016
Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessmentIan McGowan, Charlene S Dezzutti, Aaron Siegel, et al.
The Lancet. HIV|September 24, 2016
Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trialGideon Amanyire, Fred C Semitala, Jennifer Namusobya, et al.
The Lancet. HIV|September 24, 2016
Mortality in HIV-infected women, heterosexual men, and men who have sex with men in Rio de Janeiro, Brazil: an observational cohort studyLara Coelho, Beatriz Grinsztejn, Jessica L Castilho, et al.
The Lancet. HIV|May 13, 2017
Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trialNicholas I Paton, Cissy Kityo, Jennifer Thompson, et al.
The Lancet. HIV|April 14, 2018
HIV incidence in western Kenya during scale-up of antiretroviral therapy and voluntary medical male circumcision: a population-based cohort analysisMartien W Borgdorff, Daniel Kwaro, David Obor, et al.
The Lancet. HIV|June 13, 2018
The averted infections ratio: a novel measure of effectiveness of experimental HIV pre-exposure prophylaxis agentsDavid T Dunn, David V Glidden, Oliver T Stirrup, et al.
Pageof 79